Germany · Biopharma startup
Germany · NVision Imaging Technologies
NVision Imaging Technologies develops Quantum MRI agents for assessing early patient response to treatment at the metabolic level.
Funding reportedLast round: Series A
Follow NVision Imaging Technologies and see its new rounds in your feed.Start following
What company datasets say NVision Imaging Technologies raised
Funding, as reported
Reported in all52.1Min the source's currency
Rounds13
Last roundSeries A
Last round dateJun 2023
Investors listed10
On a portfolio page
Investors who name them
Each firm lists NVision Imaging Technologies on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put NVision Imaging Technologies in front of investors. Or tell us what we have wrong.